Pumpuang A, Chantratita N, Wikraiphat C; et al. (2011). "Survival of Burkholderia pseudomallei in distilled water for 16 years". Trans R Soc Trop Med Hyg105 (10-2): 598–600. doi:10.1016/j.trstmh.2011.06.004.
Ashdown LR (1979). "An improved screening technique for isolation of Pseudomonas pseudomallei from clinical specimens". Pathology11 (2): 293–7. PMID460953. doi:10.3109/00313027909061954.
Roesnita B, Tay ST, Puthucheary SD, Sam IC. (2012). "Diagnostic use of Burkholderia pseudomallei selective media in a low prevalence setting.". Trans R Soc Trop Med Hyg106 (2): 131–3. PMID22112687. doi:10.1016/j.trstmh.2011.10.007.
Goodyear A, Strange L, Rholl DA; et al. (2013). "An improved selective culture medium enhances the isolation of Burkholderia pseudomallei from contaminated specimens.". Am J Trop Med Hyg89 (5): 973–82. doi:10.4269/ajtmh.13-0119.
Inglis TJ, Chiang D, Lee GS, Chor-Kiang L (February 1998). "Potential misidentification of Burkholderia pseudomallei by API 20NE". Pathology30 (1): 62–4. PMID9534210. doi:10.1080/00313029800169685.
Podin Y, Sarovich DS, Price EP, Kaestli M, Mayo M, Hii K; et al. (2013). "Burkholderia pseudomallei from Sarawak, Malaysian Borneo are predominantly susceptible to aminoglycosides and macrolides.". Antimicrob Agents Chemother. PMID24145517. doi:10.1128/AAC.01842-13.
Hagen RM, Frickmann H, Elschner M; et al. (2011). "Rapid identification of Burkholderia pseudomallei and Burkholderia mallei by fluorescence in situ hybridization (FISH) from culture and paraffin-embedded tissue samples". Int J Med Microbiol301 (7): 585–90. PMID21658996. doi:10.1016/j.ijmm.2011.04.017.
Kespichayawattana W, Intachote P, Utaisincharoen P, Stitaya Sirisinha S (2004). "Virulent Burkholderia pseudomallei is more efficient than avirulent Burkholderia thailandensis in invasion of and adherence to cultured human epithelial cells". Microbial Pathogenesis36 (5): 287–29. PMID15043863. doi:10.1016/j.micpath.2004.01.001.
Wiersinga WJ, van der Poll T, White NJ, Day NP, Peacock SJ (2006). "Melioidosis: insights into the pathogenicity of Burkholderia pseudomallei.". Nature Reviews Microbiology4 (4): 272–82. PMID16541135. doi:10.1038/nrmicro1385.
Yabuuchi, E; Kosako, Y; Oyaizu, H; Yano, I; Hotta, H; Hashimoto, Y; Ezaki, T; Arakawa, M (1992). "Proposal of Burkholderia gen. nov. and transfer of seven species of the genus Pseudomonas homology group II to the new genus, with the type species Burkholderia cepacia (Palleroni and Holmes 1981) comb. nov.". Microbiol Immunol36 (12): 1251–1275. PMID1283774.
Chaiyaroj SC, Kotrnon K, Koonpaew S, Anantagool N, White NJ, Sirisinha S (1999). "Differences in genomic macrorestriction patterns of arabinose-positive (Burkholderia thailandensis) and arabinose-negative Burkholderia pseudomallei". Microbiology and immunology43 (7): 625–30. PMID10529102.
Ashdown LR (1979). "An improved screening technique for isolation of Pseudomonas pseudomallei from clinical specimens". Pathology11 (2): 293–7. PMID460953. doi:10.3109/00313027909061954.
Roesnita B, Tay ST, Puthucheary SD, Sam IC. (2012). "Diagnostic use of Burkholderia pseudomallei selective media in a low prevalence setting.". Trans R Soc Trop Med Hyg106 (2): 131–3. PMID22112687. doi:10.1016/j.trstmh.2011.10.007.
Inglis TJ, Chiang D, Lee GS, Chor-Kiang L (February 1998). "Potential misidentification of Burkholderia pseudomallei by API 20NE". Pathology30 (1): 62–4. PMID9534210. doi:10.1080/00313029800169685.
Podin Y, Sarovich DS, Price EP, Kaestli M, Mayo M, Hii K; et al. (2013). "Burkholderia pseudomallei from Sarawak, Malaysian Borneo are predominantly susceptible to aminoglycosides and macrolides.". Antimicrob Agents Chemother. PMID24145517. doi:10.1128/AAC.01842-13.
Hagen RM, Frickmann H, Elschner M; et al. (2011). "Rapid identification of Burkholderia pseudomallei and Burkholderia mallei by fluorescence in situ hybridization (FISH) from culture and paraffin-embedded tissue samples". Int J Med Microbiol301 (7): 585–90. PMID21658996. doi:10.1016/j.ijmm.2011.04.017.
Lumbiganon P, Tattawasatra U, Chetchotisakd P; et al. (2000). "Comparison between the antimicrobial susceptibility of Burkholderia pseudomallei to trimethoprim-sulfamethoxazole by standard disk diffusion method and by minimal inhibitory concentration determination". J Med Assoc Thai83 (8): 856–60. PMID10998837.
Wuthiekanun V, Cheng AC, Chierakul W; et al. (2005). "Trimethoprim/sulfamethoxazole resistance in clinical isolates of Burkholderia pseudomallei". J Antimicrob Chemother55 (6): 1029–31. PMID15886263. doi:10.1093/jac/dki151.
Saraya S, Soontornpas C, Chindavijak B, Mootsikapun P (2009). "In vitro interactions between cotrimoxazole and doxycycline in Burkholderia pseudomallei: how important is this combination in maintenance therapy of melioidosis?". Indian J Med Microbiol27 (1): 88–9. PMID19172079.
Kespichayawattana W, Intachote P, Utaisincharoen P, Stitaya Sirisinha S (2004). "Virulent Burkholderia pseudomallei is more efficient than avirulent Burkholderia thailandensis in invasion of and adherence to cultured human epithelial cells". Microbial Pathogenesis36 (5): 287–29. PMID15043863. doi:10.1016/j.micpath.2004.01.001.
Wiersinga WJ, van der Poll T, White NJ, Day NP, Peacock SJ (2006). "Melioidosis: insights into the pathogenicity of Burkholderia pseudomallei.". Nature Reviews Microbiology4 (4): 272–82. PMID16541135. doi:10.1038/nrmicro1385.